Novartis Hellas S.A.C.I. (Novartis Greece), a subsidiary of Novartis AG, and Alcon Pte Ltd, a former subsidiary of Novartis AG, paid a combined total of more than $233 million in criminal monetary penalties to resolve an investigation into violations of the Foreign Corrupt Practices Act (FCPA). The resolutions arose out of a Novartis Greece scheme between 2009 and 2015 to bribe employees of state-owned hospitals and clinics in Greece and to falsely record improper payments, and an Alcon scheme between 2011 and 2014 to make and falsely record improper payments in Vietnam. Novartis Greece entered into a deferred prosecution agreement in connection with a criminal information charging conspiracy to violate the anti-bribery provisions of the FCPA and conspiracy to violate the books and records provision of the FCPA. Novartis Greece agreed to pay a $225 million criminal penalty. Alcon separately entered into a deferred prosecution agreement in connection with a criminal information charging conspiracy to violate the books and records provision of the FCPA. Alcon agreed to pay a criminal penalty of approximately $8.9 million.